PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Centre de Recherche du CHUM, Montreal, QC H2X 0A9, Canada.\', \'Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, QC H3C 3J7, Canada.\', \'Department of Microbiology and Immunology, McGill University, Montreal, QC H3A 0G4, Canada.\', \'Héma-Québec, Affaires Médicales et Innovation, Montreal, QC G1V5C3, Canada.\', \'Département de Médecine, Université de Montréal, Montreal, QC H3C 3J7, Canada.\']
?:citedBy
  • -1
?:creator
?:doi
  • 53210.3390/v14030532
?:doi
?:hasPublicationType
?:journal
  • Viruses
is ?:pmid of
?:pmid
?:pmid
  • 35336940
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.805
?:rankingScore_hIndex
  • 52
is ?:relation_isRelatedTo_publication of
?:title
  • Evolution of Anti-RBD IgG Avidity following SARS-CoV-2 Infection.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35336940>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35336940>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all